Research ArticleOsteoarthritis

Teriparatide as a Chondroregenerative Therapy for Injury-Induced Osteoarthritis

See allHide authors and affiliations

Science Translational Medicine  21 Sep 2011:
Vol. 3, Issue 101, pp. 101ra93
DOI: 10.1126/scitranslmed.3002214

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • PTH to treat cartilage disorders. A new potential therapeutic approach for achondroplasia?

    To the Editor, The study by Sampson et al.(1) brings very interesting data about the potential use of PTH to treat cartilage disorders. As the authors state, the results could be considered a proof of concept that systemic administration of PTH can reach chondrocytes within an avascular environment (the cartilage) and produce a therapeutic effect.

    In achondroplasia (ACH), the key phenomenon leading to the clinic...

    Show More
    Competing Interests: None declared.